![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:620585 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of ELOVL6 mRNA | CTD | PMID:30723492 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:1332205 | 6480464 | Ethinyl Estradiol results in increased expression of ELOVL6 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:620585 | 6480464 | Ethinyl Estradiol affects the expression of ELOVL6 mRNA | CTD | PMID:17351261 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1332205 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ELOVL6 mRNA | CTD | PMID:17942748 | 17beta-estradiol | decreases expression | ISO | RGD:1332205 | 6480464 | Estradiol results in decreased expression of ELOVL6 mRNA | CTD | PMID:19484750 | 17beta-estradiol | increases expression | ISO | RGD:620585 | 6480464 | Estradiol results in increased expression of ELOVL6 protein | CTD | PMID:23180365 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1332205 | 6480464 | 2 more ... | CTD | PMID:21851831 | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | RGD:1332205 | 6480464 | 2 more ... | CTD | PMID:20005886, PMID:21851831 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1332205 | 6480464 | 2 more ... | CTD | PMID:17942748 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620585 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ELOVL6 mRNA | CTD | PMID:23238561 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:620585 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ELOVL6 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:620585 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ELOVL6 mRNA | CTD | PMID:18796159, PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1332205 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ELOVL6 mRNA | CTD | PMID:21570461, PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1332205 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ELOVL6 mRNA | CTD | PMID:19770486 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ELOVL6 mRNA | CTD | PMID:20106945, PMID:21632981 | 2,4-dinitrotoluene | affects expression | ISO | RGD:620585 | 6480464 | 2, 4-dinitrotoluene affects the expression of ELOVL6 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | ISO | RGD:620585 | 6480464 | 2, 6-dinitrotoluene affects the expression of ELOVL6 mRNA | CTD | PMID:21346803 | 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:1332205 | 6480464 | Glucosamine results in increased expression of ELOVL6 mRNA | CTD | PMID:17178593 | 2-butoxyethanol | decreases expression | ISO | RGD:1332205 | 6480464 | n-butoxyethanol results in decreased expression of ELOVL6 mRNA | CTD | PMID:19812364 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of ELOVL6 mRNA | CTD | PMID:21179406 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:620585 | 6480464 | 3 more ... | CTD | PMID:23196670 | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:620585 | 6480464 | tetrabromobisphenol A results in increased expression of ELOVL6 mRNA | CTD | PMID:27914987 | 3,4-dichloroaniline | decreases expression | ISO | RGD:620585 | 6480464 | 3, 4-dichloroaniline results in decreased expression of ELOVL6 mRNA | CTD | PMID:24172598 | 3-chloropropane-1,2-diol | increases expression | ISO | RGD:620585 | 6480464 | alpha-Chlorohydrin results in increased expression of ELOVL6 mRNA | CTD | PMID:28522335 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1332205 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL6 mRNA | CTD | PMID:16054899 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1332205 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of ELOVL6 mRNA | CTD | PMID:18648102 | 5-bromo-2'-deoxyuridine | increases expression | ISO | RGD:1332205 | 6480464 | Bromodeoxyuridine results in increased expression of ELOVL6 mRNA | CTD | PMID:24910943 | 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | increases expression | EXP | | 6480464 | 6-(4-chlorophenyl)imidazo(2 more ... | CTD | PMID:30611723 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:620585 | 6480464 | Propylthiouracil results in decreased expression of ELOVL6 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases expression | ISO | RGD:1332205 | 6480464 | Aflatoxin B1 results in decreased expression of ELOVL6 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ELOVL6 mRNA | CTD | PMID:21641981, PMID:27153756 | aflatoxin B1 | multiple interactions | ISO | RGD:620585 | 6480464 | [sulforafan co-treated with Aflatoxin B1] affects the expression of ELOVL6 mRNA | CTD | PMID:25450479 | aldehydo-D-glucosamine | increases expression | ISO | RGD:1332205 | 6480464 | Glucosamine results in increased expression of ELOVL6 mRNA | CTD | PMID:17178593 | aldehydo-D-glucose | increases expression | ISO | RGD:1332205 | 6480464 | Glucose results in increased expression of ELOVL6 mRNA | CTD | PMID:15066988 | aldehydo-D-glucose | increases expression | ISO | RGD:620585 | 6480464 | Glucose results in increased expression of ELOVL6 mRNA | CTD | PMID:16790840 | amiodarone | increases expression | ISO | RGD:1332205 | 6480464 | Amiodarone results in increased expression of ELOVL6 mRNA | CTD | PMID:24489787 | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of ELOVL6 mRNA | CTD | PMID:29248575 | ammonium chloride | affects expression | ISO | RGD:620585 | 6480464 | Ammonium Chloride affects the expression of ELOVL6 mRNA | CTD | PMID:16483693 | Aroclor 1254 | decreases expression | ISO | RGD:1332205 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of ELOVL6 mRNA | CTD | PMID:23650126 | Azaspiracid | increases expression | EXP | | 6480464 | azaspiracid results in increased expression of ELOVL6 mRNA | CTD | PMID:28939011 | benzalkonium chloride | increases expression | ISO | RGD:1332205 | 6480464 | Benzalkonium Compounds results in increased expression of ELOVL6 mRNA | CTD | PMID:31199489 | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of ELOVL6 mRNA | CTD | PMID:20359517 | benzo[a]pyrene | decreases expression | ISO | RGD:1332205 | 6480464 | Benzo(a)pyrene results in decreased expression of ELOVL6 mRNA | CTD | PMID:19770486, PMID:22228805 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ELOVL6 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397, PMID:20382639 | Benzo[k]fluoranthene | decreases expression | ISO | RGD:1332205 | 6480464 | benzo(k)fluoranthene results in decreased expression of ELOVL6 mRNA | CTD | PMID:26377693 | beta-D-glucosamine | increases expression | ISO | RGD:1332205 | 6480464 | Glucosamine results in increased expression of ELOVL6 mRNA | CTD | PMID:17178593 | beta-naphthoflavone | decreases expression | EXP | | 6480464 | beta-Naphthoflavone results in decreased expression of ELOVL6 mRNA | CTD | PMID:31225620 | bexarotene | multiple interactions | ISO | RGD:620585 | 6480464 | [bexarotene co-treated with Tamoxifen] results in increased expression of ELOVL6 mRNA | CTD | PMID:17630414 | bezafibrate | multiple interactions | EXP | | 6480464 | [Oleic Acid co-treated with Bezafibrate] results in increased expression of ELOVL6 mRNA | CTD | PMID:24534255 | bisphenol A | increases expression | ISO | RGD:1332205 | 6480464 | bisphenol A results in increased expression of ELOVL6 mRNA | CTD | PMID:21932408 | bisphenol A | decreases methylation | ISO | RGD:1332205 | 6480464 | bisphenol A results in decreased methylation of ELOVL6 promoter | CTD | PMID:27312807 | bisphenol A | affects expression | ISO | RGD:620585 | 6480464 | bisphenol A affects the expression of ELOVL6 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA | CTD | PMID:28628672 | buspirone | decreases expression | ISO | RGD:620585 | 6480464 | Buspirone results in decreased expression of ELOVL6 mRNA | CTD | PMID:24136188 | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA | CTD | PMID:29432896 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ELOVL6 mRNA | CTD | PMID:26079696 | carbon nanotube | increases expression | ISO | RGD:1332205 | 6480464 | Nanotubes, Carbon results in increased expression of ELOVL6 mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | RGD:1332205 | 6480464 | Nanotubes, Carbon analog results in decreased expression of ELOVL6 mRNA, Nanotubes, Carbon results in decreased expression of ELOVL6 mRNA | CTD | PMID:25620056 | carbon nanotube | affects expression | ISO | RGD:1332205 | 6480464 | Nanotubes, Carbon analog affects the expression of ELOVL6 mRNA | CTD | PMID:25554681 | choline | multiple interactions | ISO | RGD:1332205 | 6480464 | [Dietary Fats co-treated with Choline deficiency] results in increased expression of ELOVL6 mRNA more ... | CTD | PMID:20938992, PMID:29246445 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ELOVL6 mRNA | CTD | PMID:19561079, PMID:27594783 | clofibrate | affects expression | ISO | RGD:620585 | 6480464 | Clofibrate affects the expression of ELOVL6 mRNA | CTD | PMID:27665778 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of ELOVL6 mRNA | CTD | PMID:19376846, PMID:22941251 | cobalt dichloride | decreases expression | ISO | RGD:620585 | 6480464 | cobaltous chloride results in decreased expression of ELOVL6 mRNA | CTD | PMID:24386269 | copper atom | decreases expression | ISO | RGD:1332205 | 6480464 | Copper results in decreased expression of ELOVL6 mRNA | CTD | PMID:17205981 | copper(0) | decreases expression | ISO | RGD:1332205 | 6480464 | Copper results in decreased expression of ELOVL6 mRNA | CTD | PMID:17205981 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ELOVL6 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of ELOVL6 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RGD:1332205 | 6480464 | Cyclosporine results in decreased expression of ELOVL6 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ELOVL6 mRNA | CTD | PMID:27989131 | cyclosporin A | decreases expression | ISO | RGD:620585 | 6480464 | Cyclosporine results in decreased expression of ELOVL6 mRNA | CTD | PMID:19224547 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ELOVL6 mRNA | CTD | PMID:20106945, PMID:25562108 | D-glucose | increases expression | ISO | RGD:1332205 | 6480464 | Glucose results in increased expression of ELOVL6 mRNA | CTD | PMID:15066988 | D-glucose | increases expression | ISO | RGD:620585 | 6480464 | Glucose results in increased expression of ELOVL6 mRNA | CTD | PMID:16790840 | dexamethasone | multiple interactions | ISO | RGD:1332205 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL6 mRNA | CTD | PMID:16054899 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA | CTD | PMID:28628672 | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of ELOVL6 mRNA | CTD | PMID:25047013 | dibutyl phthalate | decreases expression | ISO | RGD:620585 | 6480464 | Dibutyl Phthalate results in decreased expression of ELOVL6 mRNA | CTD | PMID:21266533 | dichloroacetic acid | increases expression | ISO | RGD:1332205 | 6480464 | Dichloroacetic Acid results in increased expression of ELOVL6 mRNA | CTD | PMID:28962523 | dichloromethane | increases expression | EXP | | 6480464 | Methylene Chloride results in increased expression of ELOVL6 mRNA | CTD | PMID:20359517 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of ELOVL6 mRNA | CTD | PMID:28302478 | dioxygen | decreases expression | ISO | RGD:1332205 | 6480464 | Oxygen deficiency results in decreased expression of ELOVL6 mRNA | CTD | PMID:20880076 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of ELOVL6 mRNA | CTD | PMID:26516004 | diuron | decreases expression | ISO | RGD:620585 | 6480464 | Diuron results in decreased expression of ELOVL6 mRNA | CTD | PMID:21551480 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA | CTD | PMID:19167446 | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA | CTD | PMID:29432896 | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of ELOVL6 mRNA | CTD | PMID:23649840 | ethylbenzene | increases expression | EXP | | 6480464 | ethylbenzene results in increased expression of ELOVL6 mRNA | CTD | PMID:20359517 | farnesol | multiple interactions | EXP | | 6480464 | [Farnesol analog co-treated with Oleic Acid] results in increased expression of ELOVL6 mRNA | CTD | PMID:30611723 | fenofibrate | multiple interactions | EXP | | 6480464 | [Oleic Acid co-treated with Fenofibrate] affects the expression of ELOVL6 mRNA | CTD | PMID:24534255 | fenofibrate | increases expression | ISO | RGD:620585 | 6480464 | Fenofibrate results in increased expression of ELOVL6 mRNA | CTD | PMID:27665778 | fenofibrate | increases expression | ISO | RGD:1332205 | 6480464 | Fenofibrate results in increased expression of ELOVL6 mRNA | CTD | PMID:23063693 | fenofibrate | multiple interactions | ISO | RGD:1332205 | 6480464 | NR1H2 gene mutant form inhibits the reaction [Fenofibrate results in increased expression of ELOVL6 mRNA] more ... | CTD | PMID:23063693 | flavonoids | increases expression | ISO | RGD:620585 | 6480464 | Flavonoids results in increased expression of ELOVL6 mRNA | CTD | PMID:18035473 | fluoranthene | decreases expression | ISO | RGD:1332205 | 6480464 | fluoranthene results in decreased expression of ELOVL6 mRNA | CTD | PMID:28329830 | fluoranthene | multiple interactions | ISO | RGD:1332205 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ELOVL6 mRNA | CTD | PMID:28329830 | flutamide | increases expression | ISO | RGD:620585 | 6480464 | Flutamide results in increased expression of ELOVL6 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1332205 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ELOVL6 mRNA | CTD | PMID:20938992 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of ELOVL6 mRNA | CTD | PMID:23649840 | fructose | increases expression | ISO | RGD:1332205 | 6480464 | Fructose results in increased expression of ELOVL6 mRNA | CTD | PMID:15066988 | furan | increases expression | ISO | RGD:620585 | 6480464 | furan results in increased expression of ELOVL6 mRNA | CTD | PMID:25539665 | gemfibrozil | increases expression | ISO | RGD:620585 | 6480464 | Gemfibrozil results in increased expression of ELOVL6 mRNA | CTD | PMID:27665778 | glafenine | increases expression | ISO | RGD:620585 | 6480464 | Glafenine results in increased expression of ELOVL6 mRNA | CTD | PMID:24136188 | glucose | increases expression | ISO | RGD:1332205 | 6480464 | Glucose results in increased expression of ELOVL6 mRNA | CTD | PMID:15066988 | glucose | increases expression | ISO | RGD:620585 | 6480464 | Glucose results in increased expression of ELOVL6 mRNA | CTD | PMID:16790840 | GW 4064 | multiple interactions | EXP | | 6480464 | [GW 4064 co-treated with Oleic Acid] results in decreased expression of ELOVL6 mRNA | CTD | PMID:30611723 | Heptachlor epoxide | increases expression | ISO | RGD:1332205 | 6480464 | Heptachlor Epoxide results in increased expression of ELOVL6 mRNA | CTD | PMID:25270620 | hexadecanoic acid | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Oleic Acid] affects the expression of ELOVL6 mRNA | CTD | PMID:30547786 | hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOVL6 mRNA | CTD | PMID:17183730 | Indeno[1,2,3-cd]pyrene | decreases expression | ISO | RGD:1332205 | 6480464 | indeno(1 more ... | CTD | PMID:26377693 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELOVL6 mRNA | CTD | PMID:28628672 | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ELOVL6 mRNA | CTD | PMID:29432896 | L-methionine | multiple interactions | ISO | RGD:1332205 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ELOVL6 mRNA | CTD | PMID:20938992 | manganese(II) chloride | decreases expression | ISO | RGD:620585 | 6480464 | manganese chloride results in decreased expression of ELOVL6 mRNA | CTD | PMID:28801915 | mercury dichloride | increases response to substance | EXP | | 6480464 | ELOVL6 protein results in increased susceptibility to Mercuric Chloride | CTD | PMID:24118919 | mercury dichloride | affects expression | EXP | | 6480464 | Mercuric Chloride affects the expression of ELOVL6 mRNA | CTD | PMID:24118919 | metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of ELOVL6 protein | CTD | PMID:28576465 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of ELOVL6 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ELOVL6 mRNA | CTD | PMID:24118919 | N-methyl-4-phenylpyridinium | decreases expression | ISO | RGD:620585 | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ELOVL6 mRNA | CTD | PMID:28801915 | N-methyl-N-nitrosourea | increases expression | ISO | RGD:620585 | 6480464 | Methylnitrosourea results in increased expression of ELOVL6 mRNA | CTD | PMID:16525678 | nickel dichloride | affects expression | ISO | RGD:620585 | 6480464 | nickel chloride affects the expression of ELOVL6 mRNA | CTD | PMID:22110744 | nimesulide | decreases expression | ISO | RGD:620585 | 6480464 | nimesulide results in decreased expression of ELOVL6 mRNA | CTD | PMID:24136188 | o-xylene | increases expression | EXP | | 6480464 | 2-xylene results in increased expression of ELOVL6 mRNA | CTD | PMID:20359517 | obeticholic acid | decreases expression | EXP | | 6480464 | obeticholic acid results in decreased expression of ELOVL6 mRNA | CTD | PMID:27939613 | oleic acid | multiple interactions | EXP | | 6480464 | [Farnesol analog co-treated with Oleic Acid] results in increased expression of ELOVL6 mRNA more ... | CTD | PMID:24534255 more ... | paracetamol | affects expression | ISO | RGD:1332205 | 6480464 | Acetaminophen affects the expression of ELOVL6 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1332205 | 6480464 | Acetaminophen results in increased expression of ELOVL6 mRNA | CTD | PMID:26522476 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ELOVL6 mRNA | CTD | PMID:21420995 more ... | perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:620585 | 6480464 | perfluorooctane sulfonic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:18692542 | perfluorooctanoic acid | increases expression | ISO | RGD:1332205 | 6480464 | perfluorooctanoic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:18467677 | perfluorooctanoic acid | increases expression | ISO | RGD:620585 | 6480464 | perfluorooctanoic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:16221955 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:25868421 | phenobarbital | increases expression | ISO | RGD:1332205 | 6480464 | Phenobarbital results in increased expression of ELOVL6 mRNA | CTD | PMID:25270620 | phenobarbital | affects expression | ISO | RGD:1332205 | 6480464 | Phenobarbital affects the expression of ELOVL6 mRNA | CTD | PMID:23091169 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ELOVL6 mRNA | CTD | PMID:19710929 | pirinixic acid | increases activity | ISO | RGD:620585 | 6480464 | pirinixic acid results in increased activity of ELOVL6 protein | CTD | PMID:15654130 | pirinixic acid | increases expression | ISO | RGD:620585 | 6480464 | pirinixic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:15654130, PMID:27665778 | pirinixic acid | increases expression | ISO | RGD:1332205 | 6480464 | pirinixic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:16790840, PMID:18467677 | pirinixic acid | multiple interactions | ISO | RGD:1332205 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of ELOVL6 mRNA], PPARA protein promotes the reaction [pirinixic acid results in increased expression of ELOVL6 mRNA] | CTD | PMID:16790840, PMID:18467677 | pirinixic acid | decreases expression | ISO | RGD:1332205 | 6480464 | pirinixic acid results in decreased expression of ELOVL6 mRNA | CTD | PMID:18445702 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1332205 | 6480464 | Pregnenolone Carbonitrile results in increased expression of ELOVL6 mRNA | CTD | PMID:28903501 | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of ELOVL6 mRNA | CTD | PMID:18070364 | progesterone | increases expression | ISO | RGD:620585 | 6480464 | Progesterone results in increased expression of ELOVL6 protein | CTD | PMID:23180365 | propiconazole | increases expression | ISO | RGD:1332205 | 6480464 | propiconazole results in increased expression of ELOVL6 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ELOVL6 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ELOVL6 mRNA | CTD | PMID:19167446 | resveratrol | increases expression | ISO | RGD:1332205 | 6480464 | resveratrol results in increased expression of ELOVL6 protein | CTD | PMID:25505154 | Ritodrine | increases expression | ISO | RGD:1332205 | 6480464 | Ritodrine results in increased expression of ELOVL6 mRNA | CTD | PMID:23370008 | rotenone | decreases expression | ISO | RGD:620585 | 6480464 | Rotenone results in decreased expression of ELOVL6 mRNA | CTD | PMID:28374803 | Soman | decreases expression | ISO | RGD:620585 | 6480464 | Soman results in decreased expression of ELOVL6 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | RGD:1332205 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOVL6 mRNA | CTD | PMID:21641980 | sulforaphane | multiple interactions | ISO | RGD:620585 | 6480464 | [sulforafan co-treated with Aflatoxin B1] affects the expression of ELOVL6 mRNA | CTD | PMID:25450479 | tamoxifen | affects expression | ISO | RGD:1332205 | 6480464 | Tamoxifen affects the expression of ELOVL6 mRNA | CTD | PMID:20937368 | tamoxifen | multiple interactions | ISO | RGD:620585 | 6480464 | [bexarotene co-treated with Tamoxifen] results in increased expression of ELOVL6 mRNA | CTD | PMID:17630414 | Tesaglitazar | increases expression | ISO | RGD:620585 | 6480464 | tesaglitazar results in increased expression of ELOVL6 mRNA | CTD | PMID:21515302 | Tesaglitazar | multiple interactions | EXP | | 6480464 | [Oleic Acid co-treated with tesaglitazar] results in increased expression of ELOVL6 mRNA | CTD | PMID:24534255 | testosterone | decreases expression | ISO | RGD:620585 | 6480464 | Testosterone results in decreased expression of ELOVL6 protein | CTD | PMID:23180365 | tetrachloromethane | multiple interactions | ISO | RGD:1332205 | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ELOVL6 mRNA] | CTD | PMID:16006527 | tetrachloromethane | decreases expression | ISO | RGD:620585 | 6480464 | Carbon Tetrachloride results in decreased expression of ELOVL6 mRNA | CTD | PMID:19224547, PMID:31150632 | tetrachloromethane | decreases expression | ISO | RGD:1332205 | 6480464 | Carbon Tetrachloride results in decreased expression of ELOVL6 mRNA | CTD | PMID:27339419 | tetracycline | increases expression | ISO | RGD:1332205 | 6480464 | Tetracycline results in increased expression of ELOVL6 mRNA | CTD | PMID:16917069 | tetracycline | decreases expression | ISO | RGD:620585 | 6480464 | Tetracycline results in decreased expression of ELOVL6 mRNA | CTD | PMID:19224547 | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of ELOVL6 mRNA | CTD | PMID:20359517 | Tributyltin oxide | increases expression | ISO | RGD:1332205 | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of ELOVL6 mRNA | CTD | PMID:25270620 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ELOVL6 mRNA | CTD | PMID:20359517 | trichloroethene | increases expression | ISO | RGD:1332205 | 6480464 | Trichloroethylene results in increased expression of ELOVL6 mRNA | CTD | PMID:19448997 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ELOVL6 mRNA | CTD | PMID:24935251 | troglitazone | decreases expression | ISO | RGD:1332205 | 6480464 | troglitazone results in decreased expression of ELOVL6 mRNA | CTD | PMID:28973697 | troglitazone | increases expression | ISO | RGD:620585 | 6480464 | troglitazone results in increased expression of ELOVL6 mRNA | CTD | PMID:21515302 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of ELOVL6 mRNA | CTD | PMID:25572481 | trovafloxacin | decreases expression | ISO | RGD:620585 | 6480464 | trovafloxacin results in decreased expression of ELOVL6 mRNA | CTD | PMID:24136188 | tungsten | decreases expression | ISO | RGD:1332205 | 6480464 | Tungsten results in decreased expression of ELOVL6 mRNA | CTD | PMID:30912803 | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of ELOVL6 mRNA | CTD | PMID:29453283 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ELOVL6 mRNA | CTD | PMID:28818685 | valdecoxib | decreases expression | ISO | RGD:620585 | 6480464 | valdecoxib results in decreased expression of ELOVL6 mRNA | CTD | PMID:24136188 | valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOVL6 mRNA, NR1H3 protein affects the reaction [Valproic Acid results in increased expression of ELOVL6 mRNA] | CTD | PMID:17183730, PMID:30003287 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ELOVL6 mRNA | CTD | PMID:23179753 more ... | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ELOVL6 mRNA, Valproic Acid results in increased expression of ELOVL6 protein | CTD | PMID:24935251, PMID:30003287 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ELOVL6 mRNA | CTD | PMID:25979313 | valproic acid | affects expression | ISO | RGD:1332205 | 6480464 | Valproic Acid affects the expression of ELOVL6 mRNA | CTD | PMID:17963808 | vancomycin | increases expression | ISO | RGD:1332205 | 6480464 | Vancomycin results in increased expression of ELOVL6 mRNA | CTD | PMID:18930951 | vinclozolin | affects expression | ISO | RGD:620585 | 6480464 | vinclozolin affects the expression of ELOVL6 mRNA | CTD | PMID:19015723, PMID:23034163 | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of ELOVL6 mRNA | CTD | PMID:24714768 | |

Biological Process
Cellular Component
Molecular Function